- Home
- BOLT vs ITOC Comparison
BOLT vs ITOC Comparison
Compare BOLT & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BOLT | ITOC |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 9.4M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | BOLT | ITOC |
|---|---|---|
| Price | $7.01 | $0.51 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 21.3K | ★ 3.9M |
| Earning Date | 11-12-2025 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,195,000.00 | $305,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.41 | $0.39 |
| 52 Week High | $10.50 | $32.00 |
Technical Indicators
Market Signals| Indicator | BOLT | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 62.69 | 29.80 |
| Support Level | $6.14 | N/A |
| Resistance Level | $6.60 | $0.57 |
| Average True Range (ATR) | 0.45 | 0.08 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 77.36 | 26.88 |
Price Performance
Historical ComparisonAbout BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About ITOC iTonic Holdings Ltd Class A Ordinary Shares
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.